- Exchange: Natl India
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharmaceuticals
Snapshot for Biocon Ltd (BIOS)
| Open: | 276.10 | Day's Range: | 274.45 - 279.95 | Volume: | 343,648 |
|---|---|---|---|---|---|
| Previous Close: | 275.95 | 52wk Range: | 213.20 - 321.80 | 1-Yr Rtn: | +29.93% |
Key Statistics for BIOS
| Current P/E Ratio (ttm) | 10.8486 |
|---|---|
| Estimated P/E(03/2014) | 14.3683 |
| Relative P/E vs. SENSEX | 0.7061 |
| Earnings Per Share (INR) (ttm) | 25.4410 |
| Est. EPS (INR) (03/2014) | 19.2090 |
| Est. PEG Ratio | 0.6561 |
| Market Cap (M INR) | 55,200.00 |
| Shares Outstanding (M) | 200.00 |
| 30 Day Average Volume | 267,395 |
| Price/Book (mrq) | 2.0485 |
| Price/Sale (ttm) | 2.2739 |
| Dividend Indicated Gross Yield | 1.81% |
| Cash Dividend (INR) | 5.0000 |
| Last Dividend | |
| 5 Year Dividend Growth | 27.23% |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BIOS
Company Profile & Key Executives for BIOS
Biocon Ltd., is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immunosuppressants and anti-diabetic drugs. Biocon also manufactures specialty enzymes and new enzyme applications besides providing clinical and custom research services.
| Kiran Mazumdar ShawChairman/Mng Director/Founder | John ShawVice Chairman/Founder |
| Arun Suresh ChandavarkarChief Operating Officer | Murali Krishnan K NPresident:Group Finance |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BIOS News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page